Computational biology insights into genotype-clinical phenotype-protein phenotype relationships between novel SLC26A2 variants identified in inherited skeletal dysplasias
Authors:
- 22 August 2022
- journal article
- research article
- Published by Elsevier in European Journal of Medical Genetics
- Vol. 65 (10) , 104595
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- STAS Domain Structure and FunctionCellular Physiology and Biochemistry, 2011
- Genotype–phenotype correlation in DTDST dysplasias: Atelosteogenesis type II and diastrophic dysplasia variant in one familyAmerican Journal of Medical Genetics Part A, 2010
- Normal mode analysis for proteinsJournal of Molecular Structure: THEOCHEM, 2009
- Nonsense-mediated mRNA decay (NMD) mechanismsNature Structural & Molecular Biology, 2009
- Diastrophic dysplasia and atelosteogenesis type II as expression of compound heterozygosis: First report of a Mexican patient and genotype–phenotype correlationAmerican Journal of Medical Genetics Part A, 2004
- Nonsense-mediated mRNA decay: terminating erroneous gene expressionCurrent Opinion in Cell Biology, 2004
- Protein degradation and protection against misfolded or damaged proteinsNature, 2003
- Mutations in the diastrophic dysplasia sulfate transporter (DTDST) gene (SLC26A2): 22 novel mutations, mutation review, associated skeletal phenotypes, and diagnostic relevanceHuman Mutation, 2001
- Achondrogenesis type IB is caused by mutations in the diastrophic dysplasia sulphate transporter geneNature Genetics, 1996
- The diastrophic dysplasia gene encodes a novel sulfate transporter: Positional cloning by fine-structure linkage disequilibrium mappingCell, 1994